Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Gastrointest Endosc. 2009 Nov 17;71(1):53–63. doi: 10.1016/j.gie.2009.08.027

Table 3. Descriptive statistics and hypothesis testing results for pancreas data.

Rows 1–3: Means and standard deviations of spectral parameters for normal pancreas (NP), pancreatic cancer (PC), and chronic pancreatitis (CP) cases from Study 2 (validation study). Row 4: The p-values resulting from ANOVA calculations assuming equal variance between groups. Rows 5–7: The p-values resulting from multiple comparisons using Bonferroni's criterion. Rows 8–10: Means and standard deviations of spectral parameters normal pancreas (NP), pancreatic cancer (PC), and chronic pancreatitis (CP) cases from both studies. Row 11: The p-values resulting from ANOVA calculations assuming equal variance between groups. Rows 12–14: The p-values resulting from multiple comparisons. Bonferroni's criterion was used for slope and intercept, whereas Tamhane's T2 criterion was used for midband fit and R2.

Data Set B-mode appearance Midband Fit (dB) Slope (dB/MHz) Intercept (dB) Correlation coeff. R2
Study 2 (Validation Study) Normal Pancreas (n = 15) −40.9±3.8 −1.44±0.31 −32.2±4.7 0.31±0.08
Pancreatic Cancer (n = 10) −53.3±1.2 −0.94±0.33 −47.6±2.8 0.17±0.05
Chronic Pancreatitis (n = 3) −49.5±3.3 −1.28±0.54 −41.8±6.5 0.25±0.10
ANOVA p-value < 0.001 < 0.01 < 0.001 < 0.001
NP vs. PC p-value < 0.01 < 0.01 < 0.001 < 0.001
NP vs. CP p-value < 0.001 1 < 0.01 0.59
PC vs. CP p-value 0.21 0.43 0.14 0.27

Study 1 + Study 2 Normal Pancreas (n = 40) −41.5±3.4 −1.86±0.76 −30.3±5.4 0.40±0.12
Pancreatic Cancer (n = 13) −53.2±1.1 −0.98±0.31 −47.3±2.6 0.16±0.04
Chronic Pancreatitis (n = 7) −50.2±2.1 −1.21±0.34 −42.8±4.0 0.26±0.07
ANOVA p-value < 0.001 < 0.01 < 0.001 < 0.001
NP vs. PC p-value < 0.001 < 0.01 < 0.001 < 0.001
NP vs. CP p-value < 0.001 0.055 < 0.001 < 0.01
PC vs. CP p-value < 0.05 1 0.14 < 0.05